Journal of Experimental Medicine

CSHL, partners track COVID-19 culprit to tricky NET

By GREGORY ZELLER // An international research consortium with Long Island roots may have identified the culprit behind COVID-19’s worst cases. It’s been well-documented that a large majority of patients who contract SARS-CoV-2, the virus that causes the COVID-19 disease, suffer only mild to moderate symptoms and fully recover. Much more documented: The novel coronavirus can kill, with severe COVID-19 infections leading to Acute Respiratory Distress Syndrome, pulmonary inflammation, airway-blocking mucus secretions, blood clots and…


For lupus patients, a possible ACE in the hole

By GREGORY ZELLER // A common pharmaceutical treatment for hypertension could be the key to preserving brain function in lupus patients. So says data published this month in the Journal of Experimental Medicine by an international team of scientists led by the redoubtable Betty Diamond, head of the Feinstein Institute for Medical Research’s Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases and a professor of molecular medicine at the Donald and Barbara Zucker School of Medicine…